Supplemental Table 1. Kaplan-Meier analyses to estimate median time to toxicity by lactate dehydrogenase levels and stage at diagnosis.

Supplemental data table for publication titled "Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation". The table illustrates the time to any organ system toxicity development by level of lactate dehydrogenase (elevated levels defined as 210 U/L by institutional standards), stratified by stage of melanoma tumor at time of immune checkpoint inhibitor therapy initiation.